For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 71,043 | |||
| General and administrative | 22,569 | |||
| Total operating expenses | 93,612 | |||
| Operating loss | -93,612 | |||
| Interest income | 4,017 | |||
| Other (expense) income, net | -11 | |||
| Total other income, net | 4,006 | |||
| Net loss before income tax | -89,606 | |||
| Income tax (expense) benefit | 49 | |||
| Net loss | -89,655 | |||
| Cumulative translation adjustment arising during the period | 0 | |||
| Unrealized (loss) gain on marketable securities | -12 | |||
| Comprehensive loss | -89,667 | |||
| Basic EPS | -2.12 | |||
| Diluted EPS | -2.12 | |||
| Basic Average Shares | 42,221,808 | |||
| Diluted Average Shares | 42,221,808 | |||
PepGen Inc. (PEPG)
PepGen Inc. (PEPG)